Welcome to the May-June issue of the
Journal of Clinical Psychopharmacology. There are many interesting articles in this issue. I would like to highlight a few of them. Pompili and colleagues report (pp. 304-309) on the association between finasteride and adverse psychiatric effects that can persist in association with sexual dysfunction after discontinuing finasteride treatment. Buchanan and colleagues report (pp.236-243) on the results of a study on combined oxytocin and cognitive behavioral social skills training for social function in people with schizophrenia. Rakofsky and colleagues report (pp. 295-303) on the role of depression and antidepressants in dry eye disease.
With this issue, JCP is starting our presentation of podcasts. One podcast is a discussion by Drs. Mischel and Balon regarding their Commentary on esketamine entitled “Esketamine – A Drug to Treat Resistant Depression That Brings More Questions Than Answers” (pp. 233-235). The other podcast is my Editorial, “The Pitfalls of Psychotropic Polypharmacy (pp. 227-232). And many other interesting Original Contributions, Brief Reports, and Letters to the Editor are in this issue. And finally, an important salute to our invaluable reviewers (pp.356-358)!
Anthony J. Rothschild, MD
Editor-in-Chief
